Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ning
Contact Ning, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9
Cite Jump to ExpandCollapse Drug AnnotationNovember 24, 2025 Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9 Click to copy article linkArticle link copied! Katrina L. Jackson* Katrina L. Jackson C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, United States *Email: [email protected] Ning Yin Ning Yin C4 Therapeutics, Inc., 490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472, United States Roman V.
Molybdenum Carbide Electro‐Converted from CO2 and MoO3 for Hydrogen Evolution Reaction
Conflict of Interests The authors declare no conflict of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. Supporting Information Filename Description cctc70425-sup-0001-SuppMat.docx1.8 MB Supporting Information References 1, , , , , Langmuir 2022, 38, 4341–4350, 2, , , Chin. J. Catal. 2022, 43, 636–678. 3, , , , , , , , , J. Adv. Ceram. 2022, 11, 1294–1306. https://doi.org/10.1007/s40145-022-0610-6.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ning
Contact Ning, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack